The Hourly View for BGNE
At the moment, BGNE (Get Ratings)’s price is down $-3.84 (-1.08%) from the hour prior. This is the 2nd hour in a row BGNE has seen its price head down. If you’re a trend trader, consider that the strongest clear trend on the hourly chart exists on the 50 hour timeframe. The moving averages on the hourly timeframe suggest a choppiness in price, as the 20, 50, 100 and 200 are all in a mixed alignment — meaning the trend across timeframes is inconsistent, indicating a potential opportunity for rangebound traders.
Out of Pharmaceutical Products stocks, BGNE ranks 312th in regards to today’s price percentage change.
BGNE’s Technical Outlook on the Daily Chart
At the time of this writing, BGNE’s price is down $-5.37 (-1.51%) from the day prior. This is a reversal of the price action on the previous day, in which price moved up. If you’re a trend trader, consider that the strongest clear trend on the daily chart exists on the 20 day timeframe. Of note is that the 50 day changed directions on BGNE; it is now pointing up. The moving averages on the daily timeframe suggest a choppiness in price, as the 20, 50, 100 and 200 are all in a mixed alignment — meaning the trend across timeframes is inconsistent, indicating a potential opportunity for rangebound traders. BeiGene Ltd’s price action over the past 90 days can be seen via the chart below.
For BGNE News Traders
News traders keeping an eye on BGNE may find value in this recent story:
Mirati Therapeutics: Another Growth Cycle Approaching
Photo by Geber86/E+ via Getty Images “When you sell in desperation, you always sell cheap.” – Peter Lynch When you invest in biotech, it’s very important to focus on the lead medicines and their underlying science. In doing so, you can capture multiple-fold profits when you buy a young growth…
Want More Great Investing Ideas?
9 “MUST OWN” Growth Stocks for 2021
5 WINNING Stock Chart Patterns
7 Best ETFs for the NEXT Bull Market